- Previous Close
2.6200 - Open
2.5600 - Bid 2.6100 x --
- Ask 2.6650 x --
- Day's Range
2.5600 - 2.5600 - 52 Week Range
2.0850 - 7.3100 - Volume
1,200 - Avg. Volume
54 - Market Cap (intraday)
49.862M - Beta (5Y Monthly) 1.38
- PE Ratio (TTM)
-- - EPS (TTM)
-1.2900 - Earnings Date Apr 29, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software. The company was founded in 2002 and is based in Valbonne, France.
www.mediantechnologies.comRecent News: 4ZG.F
View MorePerformance Overview: 4ZG.F
Trailing total returns as of 4/14/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4ZG.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4ZG.F
View MoreValuation Measures
Market Cap
50.50M
Enterprise Value
63.16M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.36
Price/Book (mrq)
--
Enterprise Value/Revenue
2.89
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-113.57%
Return on Assets (ttm)
-56.84%
Return on Equity (ttm)
--
Revenue (ttm)
22.32M
Net Income Avi to Common (ttm)
-25.35M
Diluted EPS (ttm)
-1.2900
Balance Sheet and Cash Flow
Total Cash (mrq)
16.09M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-13.92M